Lexicon Pharmaceuticals (LXRX) Posts Q2 Loss of 6c/Share

July 30, 2013 6:44 AM EDT Send to a Friend

Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q1 EPS of ($0.06), $0.01 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Lexicon Pharmaceuticals (LXRX) Posts Q2 Loss of 6c/Share

Member Login

Free News Feed